(4.3) (79.6) Total comprehensive income for the year 132.6 209.2 228.1 246.5 18.4 8.1 816.4 552.0 264.4 47.9 2019 2018Change QoQ Change YoYConsolidated financial statements Q1-2019 Q2-2019 Q3-2019 Q4
., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 195/2560 November 8, 2017 Subject: Clarification of the Operating Result for the significant change Attention
., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 195/2560 November 8, 2017 Subject: Clarification of the Operating Result for the significant change - Update
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
55.74 million in 1Q19 from Baht 26.23 million in 1Q18. (Unit : Baht million) 31 MAR 19 (quarterly) 31 MAR 18 (quarterly) Change Revenues from Hospital Operations 200.01 139.21 43.68% Gross Profit 90.43
1Q19. (Unit : Million THB) 31 March 2020 (3 months period) 31 March 2019 (3 months period) Change Revenues from Hospital Operations 183.19 200.01 ‐8.41% Gross Profit 55.62 90.43 ‐38.49
confidence and higher household incomes. In early October, Bank of Thailand announced tighter mortgage rules in order to cool the property market and avoid the escalation of risks. Domestically, private
incurred in marketing expenses and employee expense from coffee shop business. Summary of Financial Statement of Positions 30-Jun-19 31-Dec-18 Change %Change Assets Cash and Cash Equivalents 232.7 21.4 211.3
period last year while EBITDA was slightly behind the previous year -5% due to the one shot SG&A costs. Price has generally met expectations and every effort will be Q1 2020 Q1 2019 YoY change YoY % change
ended as of September 30, 2021, which can be summarized as follows: 1) Profit & Loss Analysis : Q3 2021 (3 Months) (Unit : Million Baht unless otherwise stated) Q3 2021 Q3 2020 Change Amount % Change